Q&A With Colleen Kelly, MD, From Brown Alpert Medical School: Fecal Microbiota Transplant Moves Into Mainstream Treatment for C-Difficie

Video

What once was viewed to be an unscientific approach to help treat C-difficile, fecal microbiota transplant has become not only an accepted method of treatment, but also the preferred method in many patients.

What once was viewed to be an unscientific approach to help treat C-difficile, fecal microbiota transplant has become not only an accepted method of treatment, but also the preferred method in many patients.

Colleen Kelly discussed the procedure during the American College of Physicians Internal Medicine meeting in Boston. As the procedure has developed it has become easier for doctors outside of gastroenterology to handle the transplants in some cases. Kelly said it is important that the donor for the transplant is properly screened to ensure ultimate success.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.